根据冠状动脉疾病的复杂性和指导重血管化方法的最佳值的结果:FAME 3试验
Luke P Dawson1, Yuhei Kobayashi2, Frederik M Zimmermann3
1Stanford University School of Medicine, Stanford, California, USA; Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia.
JACC. Cardiovascular interventions
|August 28, 2024
概括
穿皮冠状动脉干预 (PCI) 和冠状动脉旁路移植 (CABG) 在多血管疾病 (MVD) 患者中显示了可比的结果,SYNTAX得分高达24. 这一发现扩大了考虑PCI作为CABG可行的替代品的标准.
科学领域:
- 心血管医学 心血管医学
- 干预心脏病学 干预心脏病学
- 心脏外科手术 心脏外科手术
背景情况:
- 冠状动脉疾病的复杂性影响了多血管疾病 (MVD) 中的重血管化策略决策.
- 目前的指导方针经常使用冠状动脉复杂性得分来指导皮肤通冠状动脉干预 (PCI) 和冠状动脉旁路移植 (CABG) 之间的治疗选择.
研究的目的:
- 评估冠状动脉复杂性对PCI和CABG结果的影响.
- 确定SYNTAX得分 (SS) 的最佳值,在没有左主疾病的MVD患者中,PCI是CABG的合理替代方案.
主要方法:
- 来自FAME 3随机试验的1444名MVD患者 (710名CABG与734名PCI) 的分析.
- 分析了SYNTAX得分 (SS),使用受限制的立方线和逻辑回归与相互作用术语.
- 考克斯回归模型确定了PCI和CABG之间可比结果的最佳SS值.
主要成果:
- 观察到的平均SS值为25.9 ± 7.1 .
- 在1年和3年复合终点上,重血管化策略和SS之间的显著相互作用 (P <0.05).
- 对于PCI和CABG的结果是可比的,最高SS为24 (P=0.332),这一值涵盖了44%的患者.
结论:
- PCI和CABG在MVD患者 (没有左侧主要疾病) 中显示了相似的SS值到20多岁中期的结果.
- 24的SS值允许识别一个更大的患者群体适合PCI作为CABG的替代品.
更多相关视频
10:28Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
4.9K
05:41Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
Published on: December 16, 2022
3.4K
相关概念视频
01:26Coronary Artery Disease II: Pathophysiology
1.1K
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.1K
01:30Coronary Artery Disease III: Clinical Manifestations
620
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
620
01:26Coronary Artery Disease IV: Preventive Measures
890
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
890
01:27Coronary Artery Disease V: Interprofessional Care
444
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
444
01:30Acute Coronary Syndrome III: Diagnostic Studies
495
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
495
01:26Atherosclerosis III: Management
741
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
741